Autopsy report · NCT04941989

A Study in Healthy Subjects to Assess the Safety, Tolerability and Pharmacokinetics of HTL0022562

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Early termination of study pending evaluation of emerging preclinical profile.”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 6 months before it stopped.
33 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: Nxera Pharma UK Limited
Sponsor type: Industry
Conditions: Healthy
Interventions: HTL0022562; Placebo
Participants: 33
Sites: 1
Countries: United Kingdom

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.